HLS Therapeutics Competitors and Similar CompaniesClear all
HLS Therapeutics's competitors and similar companies include BeOne Medicines.
 HLS Therapeutics HLS Therapeutics is a specialty pharmaceutical company dedicating itself to acquiring and distributing commercial-stage mature, or legacy, branded pharmaceutical drugs. |  BeOne Medicines BeOne Medicines (formerly known as BeiGene) is a biotechnology company that discovers and develops oncology cancer treatments. | |
Founding Date | Founding Date 2015 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Toronto, CA HQ Winnipeg, CA Bryn Mawr, US Mount Laurel Township, US | |
Employees | Employees 92 | Employees 12,0009% increase |
Valuation ($) | Valuation ($) 79.3 m | Valuation ($) 23.8 b |
Financial | ||
Revenue (est.) | Revenue (est.) $55.5m (FY, 2025) | Revenue (est.) $5.3b (FY, 2025) |
Cost of goods | Cost of goods $10.1m (FY, 2025) | Cost of goods $668.5m (FY, 2025) |
Gross profit | Gross profit $45.4m (FY, 2025) | Gross profit $4.7b (FY, 2025) |
Net income | Net income ($12.4m) (FY, 2025) | Net income $286.9m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 75m |
For sources of this data, please see the company profile
View Company Profiles
BeOne Medicines
HQ
Cambridge, US
Employees
12,000↑ 9% increase
BeOne Medicines (formerly known as BeiGene) is a biotechnology company that discovers and develops oncology cancer treatments.
View company